{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:10:08Z","timestamp":1783512608149,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26473-4","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:10:55Z","timestamp":1764249055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In-silico identification of novel Cis-aconitate decarboxylase inhibitors as potential anti-inflammatory agents using molecular docking and dynamics"],"prefix":"10.1038","volume":"15","author":[{"given":"Mohammad Darvish","family":"Khadem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Pirmoradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3258-8550","authenticated-orcid":false,"given":"Mohammad Reza","family":"Tabandeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Zarezade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohre","family":"Monjezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"7958","key":"26473_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","volume":"616","author":"AV Sadybekov","year":"2023","unstructured":"Sadybekov, A. V. & Katritch, V. Computational approaches streamlining drug discovery. Nature 616 (7958), 673\u2013685 (2023).","journal-title":"Nature"},{"issue":"6","key":"26473_CR2","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/molecules25061375","volume":"25","author":"X Lin","year":"2020","unstructured":"Lin, X., Li, X. & Lin, X. A review on applications of computational methods in drug screening and design. Molecules 25 (6), 1375 (2020).","journal-title":"Molecules"},{"issue":"12","key":"26473_CR3","first-page":"2711","volume":"34","author":"N Kalsi","year":"2016","unstructured":"Kalsi, N., Gopalakrishnan, C., Rajendran, V. & Purohit, R. Biophysical aspect of phosphatidylinositol 3-kinase and role of oncogenic mutants (E542K & E545K). J. Biomol. Struct. Dynamics. 34 (12), 2711\u20132721 (2016).","journal-title":"J. Biomol. Struct. Dynamics"},{"issue":"12","key":"26473_CR4","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1007\/s00894-013-2044-0","volume":"19","author":"B Kamaraj","year":"2013","unstructured":"Kamaraj, B., Rajendran, V., Sethumadhavan, R. & Purohit, R. In-silico screening of cancer associated mutation on PLK1 protein and its structural consequences. J. Mol. Model. 19 (12), 5587\u20135599 (2013).","journal-title":"J. Mol. Model."},{"issue":"19","key":"26473_CR5","doi-asserted-by":"publisher","first-page":"9424","DOI":"10.1080\/07391102.2022.2141895","volume":"41","author":"B Sharma","year":"2023","unstructured":"Sharma, B., Bhattacherjee, D., Zyryanov, G. V. & Purohit, R. An insight from computational approach to explore novel, high-affinity phosphodiesterase 10A inhibitors for neurological disorders. J. Biomol. Struct. Dynamics. 41 (19), 9424\u20139436 (2023).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"26473_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-44599-7_1","volume-title":"Nrf2 and its Modulation in Inflammation","author":"R Wang","year":"2020","unstructured":"Wang, R. Molecular mechanisms of Nrf2 in inflammation: interactions between Nrf2 and inflammatory mediators. In Nrf2 and its Modulation in Inflammation (ed. Perez, V. I.) 1\u201321 (Springer, 2020). https:\/\/doi.org\/10.1007\/978-3-030-44599-7_1."},{"issue":"1","key":"26473_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/ijms24010641","volume":"24","author":"AM Soliman","year":"2022","unstructured":"Soliman, A. M. & Barreda, D. R. Acute inflammation in tissue healing. Int. J. Mol. Sci. 24 (1), 641. https:\/\/doi.org\/10.3390\/ijms24010641 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"26473_CR8","doi-asserted-by":"publisher","first-page":"628192","DOI":"10.1155\/2015\/628192","volume":"2015","author":"NP Rocha","year":"2015","unstructured":"Rocha, N. P., De Miranda, A. S. & Teixeira, A. L. Insights into neuroinflammation in parkinson\u2019s disease: from biomarkers to anti-inflammatory based therapies. Biomed. Res. Int. 2015, 628192. https:\/\/doi.org\/10.1155\/2015\/628192 (2015).","journal-title":"Biomed. Res. Int."},{"key":"26473_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22159\/ijpps.2024v16i6.49530","volume":"16","author":"AP Singh","year":"2024","unstructured":"Singh, A. P., Sharma, A. K. & Singh, T. G. Unlocking the therapeutic potential: exploring NF-\u03baB as a viable target for diverse Pharmacological approaches. Int. J. Pharm. Pharm. Sci. 16, 1\u20139 (2024).","journal-title":"Int. J. Pharm. Pharm. Sci."},{"issue":"19","key":"26473_CR10","doi-asserted-by":"publisher","first-page":"7336","DOI":"10.3390\/ijms21197336","volume":"21","author":"E Dolcetti","year":"2020","unstructured":"Dolcetti, E. et al. Emerging role of extracellular vesicles in the pathophysiology of multiple sclerosis. Int. J. Mol. Sci. 21 (19), 7336. https:\/\/doi.org\/10.3390\/ijms21197336 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"26473_CR11","doi-asserted-by":"publisher","first-page":"111428","DOI":"10.1016\/j.biopha.2021.111428","volume":"138","author":"YS Feng","year":"2021","unstructured":"Feng, Y. S., Tan, Z. X., Wu, L. Y., Dong, F. & Zhang, F. The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases. Biomed. Pharmacother. 138, 111428. https:\/\/doi.org\/10.1016\/j.biopha.2021.111428 (2021).","journal-title":"Biomed. Pharmacother"},{"issue":"19","key":"26473_CR12","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1073\/pnas.1218599110","volume":"110","author":"A Michelucci","year":"2013","unstructured":"Michelucci, A. et al. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing Itaconic acid production. Proc. Natl. Acad. Sci. U S A. 110 (19), 7820\u20137825. https:\/\/doi.org\/10.1073\/pnas.1218599110 (2013).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"26473_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.copbio.2020.11.005","volume":"68","author":"T Cordes","year":"2021","unstructured":"Cordes, T. & Metallo, C. M. Exploring the evolutionary roots and physiological function of Itaconate. Curr. Opin. Biotechnol. 68, 144\u2013150. https:\/\/doi.org\/10.1016\/j.copbio.2020.11.005 (2021).","journal-title":"Curr. Opin. Biotechnol."},{"issue":"5","key":"26473_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/08830185.2022.2067153","volume":"42","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. The IRG1-Itaconate axis: a regulatory hub for immunity and metabolism in macrophages. Int. Rev. Immunol. 42 (5), 364\u2013378. https:\/\/doi.org\/10.1080\/08830185.2022.2067153 (2023).","journal-title":"Int. Rev. Immunol."},{"key":"26473_CR15","doi-asserted-by":"publisher","first-page":"103758","DOI":"10.1016\/j.mcn.2022.103758","volume":"122","author":"MD Khadem","year":"2022","unstructured":"Khadem, M. D., Tabandeh, M. R., Haschemi, A., Kheirollah, A. & Shahriari, A. Dimethyl Itaconate reprograms neurotoxic to neuroprotective primary astrocytes through the regulation of NLRP3 inflammasome and NRF2\/HO-1 pathways. Mol. Cell. Neurosci. 122, 103758. https:\/\/doi.org\/10.1016\/j.mcn.2022.103758 (2022).","journal-title":"Mol. Cell. Neurosci."},{"key":"26473_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.rvsc.2022.07.024","volume":"152","author":"MR Tabandeh","year":"2022","unstructured":"Tabandeh, M. R., Jozaie, S., Ghotbedin, Z. & Gorani, S. Dimethyl Itaconic acid improves viability and steroidogenesis and suppresses cytokine production in LPS-treated bovine ovarian granulosa cells by regulating TLR4\/NF-\u03baB, NLRP3, JNK signaling pathways. Res. Vet. Sci. 152, 89\u201398. https:\/\/doi.org\/10.1016\/j.rvsc.2022.07.024 (2022).","journal-title":"Res. Vet. Sci."},{"issue":"2","key":"26473_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/cmi.2015.02","volume":"13","author":"MJ Uddin","year":"2016","unstructured":"Uddin, M. J. et al. IRG1 induced by Heme oxygenase-1\/carbon monoxide inhibits LPS-mediated sepsis and pro-inflammatory cytokine production. Cell. Mol. Immunol. 13 (2), 170\u2013179. https:\/\/doi.org\/10.1038\/cmi.2015.02 (2016).","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"26473_CR18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1084\/jem.20180118","volume":"215","author":"S Nair","year":"2018","unstructured":"Nair, S. et al. Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection. J. Exp. Med. 215 (4), 1035\u20131045. https:\/\/doi.org\/10.1084\/jem.20180118 (2018).","journal-title":"J. Exp. Med."},{"issue":"16","key":"26473_CR19","doi-asserted-by":"publisher","first-page":"7313","DOI":"10.1128\/jvi.00563-16","volume":"90","author":"K Ren","year":"2016","unstructured":"Ren, K. et al. Suppression of IRG-1 reduces inflammatory cell infiltration and lung injury in respiratory syncytial virus infection by reducing production of reactive oxygen species. J. Virol. 90 (16), 7313\u20137322. https:\/\/doi.org\/10.1128\/jvi.00563-16 (2016).","journal-title":"J. Virol."},{"key":"26473_CR20","doi-asserted-by":"publisher","first-page":"6729379","DOI":"10.1155\/2016\/6729379","volume":"2016","author":"S McNeal","year":"2016","unstructured":"McNeal, S. et al. Association of immunosuppression with DR6 expression during the development and progression of spontaneous ovarian cancer in laying Hen model. J. Immunol. Res. 2016, 6729379. https:\/\/doi.org\/10.1155\/2016\/6729379 (2016).","journal-title":"J. Immunol. Res."},{"issue":"9","key":"26473_CR21","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1172\/JCI99169","volume":"128","author":"JM Weiss","year":"2018","unstructured":"Weiss, J. M. et al. Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors. J. Clin. Invest. 128 (9), 3794\u20133805. https:\/\/doi.org\/10.1172\/JCI99169 (2018).","journal-title":"J. Clin. Invest."},{"issue":"5","key":"26473_CR22","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3892\/or.2014.3474","volume":"32","author":"J Pan","year":"2014","unstructured":"Pan, J. et al. Immune responsive gene 1, a novel oncogene, increases the growth and tumorigenicity of glioma. Oncol. Rep. 32 (5), 1957\u20131966. https:\/\/doi.org\/10.3892\/or.2014.3474 (2014).","journal-title":"Oncol. Rep."},{"key":"26473_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2022.06.002","author":"KM Scheurlen","year":"2022","unstructured":"Scheurlen, K. M. et al. The NOTCH4-GATA4-IRG1 axis as a novel target in early-onset colorectal cancer. Cytokine Growth Factor. Rev. https:\/\/doi.org\/10.1016\/j.cytogfr.2022.06.002 (2022).","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"D1","key":"26473_CR24","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47 (D1), D607\u2013D613. https:\/\/doi.org\/10.1093\/nar\/gky1131 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"26473_CR25","doi-asserted-by":"publisher","first-page":"329a","DOI":"10.1016\/j.bpj.2018.11.1783","volume":"116","author":"SK Burley","year":"2019","unstructured":"Burley, S. K. & RCSB Protein Data Bank. Sustaining a living digital data resource that enables breakthroughs in scientific research and biomedical education. Biophys. J. 116 (3), 329a (2019).","journal-title":"Biophys. J."},{"key":"26473_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"64","author":"CA Lipinski","year":"2012","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv Rev. 64, 4\u201317. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1 (2012).","journal-title":"Adv. Drug Deliv Rev."},{"issue":"12","key":"26473_CR27","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber, D. F. et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45 (12), 2615\u20132623 (2002).","journal-title":"J. Med. Chem."},{"issue":"1","key":"26473_CR28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41401-019-0228-6","volume":"41","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. CB-Dock: A web server for cavity detection-guided protein\u2013ligand blind Docking. Acta Pharmacol. Sin. 41 (1), 138\u2013144. https:\/\/doi.org\/10.1038\/s41401-019-0228-6 (2020).","journal-title":"Acta Pharmacol. Sin"},{"key":"26473_CR29","doi-asserted-by":"publisher","first-page":"1360226","DOI":"10.3389\/fphar.2024.1360226","volume":"15","author":"D Gheidari","year":"2024","unstructured":"Gheidari, D., Mehrdad, M. & Hoseini, F. Virtual screening, molecular docking, MD simulation studies, DFT calculations, ADMET, and drug likeness of Diaza-adamantane as potential MAPKERK inhibitors. Front. Pharmacol. 15, 1360226 (2024).","journal-title":"Front. Pharmacol."},{"issue":"11","key":"26473_CR30","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.tibs.2019.06.004","volume":"44","author":"PW Hildebrand","year":"2019","unstructured":"Hildebrand, P. W., Rose, A. S. & Tiemann, J. K. Bringing molecular dynamics simulation data into view. Trends Biochem. Sci. 44 (11), 902\u2013913. https:\/\/doi.org\/10.1016\/j.tibs.2019.06.004 (2019).","journal-title":"Trends Biochem. Sci."},{"issue":"27","key":"26473_CR31","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1002\/jcc.26011","volume":"40","author":"C Kutzner","year":"2019","unstructured":"Kutzner, C. et al. More Bang for your buck: improved use of GPU nodes for GROMACS 2018. J. Comput. Chem. 40 (27), 2418\u20132431. https:\/\/doi.org\/10.1002\/jcc.26011 (2019).","journal-title":"J. Comput. Chem."},{"issue":"10","key":"26473_CR32","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco, M. S., Vald\u00e9s-Tresanco, M. E., Valiente, P. A. & Moreno, E. gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J. Chem. Theory Comput. 17 (10), 6281\u20136291 (2021).","journal-title":"J. Chem. Theory Comput."},{"issue":"9","key":"26473_CR33","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires, D. E., Blundell, T. L. & Ascher, D. B. PkCSM: predicting small-molecule Pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58 (9), 4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104 (2015).","journal-title":"J. Med. Chem."},{"issue":"1","key":"26473_CR34","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7 (1), 42717. https:\/\/doi.org\/10.1038\/srep42717 (2017).","journal-title":"Sci. Rep."},{"issue":"19","key":"26473_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.mencom.2009.09.001","volume":"5","author":"FN Novikov","year":"2009","unstructured":"Novikov, F. N. & Chilov, G. G. Molecular docking: theoretical background, practical applications and perspectives. Mendeleev Commun. 5 (19), 237\u2013242. https:\/\/doi.org\/10.1016\/j.mencom.2009.09.001 (2009).","journal-title":"Mendeleev Commun."},{"issue":"12","key":"26473_CR36","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2174\/1568026023392841","volume":"2","author":"F Darvas","year":"2002","unstructured":"Darvas, F. et al. Silico and ex Silico ADME approaches for drug discovery. Curr. Top. Med. Chem. 2 (12), 1287\u20131304. https:\/\/doi.org\/10.2174\/1568026023392841 (2002).","journal-title":"Curr. Top. Med. Chem."},{"issue":"6","key":"26473_CR37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-2125.2004.02194.x","volume":"58","author":"DK Walker","year":"2004","unstructured":"Walker, D. K. The use of Pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development. Br. J. Clin. Pharmacol. 58 (6), 601\u2013608. https:\/\/doi.org\/10.1111\/j.1365-2125.2004.02194.x (2004).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"26473_CR38","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/prot.10465","volume":"52","author":"ML Verdonk","year":"2003","unstructured":"Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W. & Taylor, R. D. Improved protein\u2013ligand Docking using GOLD. Proteins: Struct. Funct. Bioinform. 52 (4), 609\u2013623. https:\/\/doi.org\/10.1002\/prot.10465 (2003).","journal-title":"Proteins: Struct. Funct. Bioinform"},{"issue":"11","key":"26473_CR39","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0960-894X(00)00172-4","volume":"10","author":"WL Jorgensen","year":"2000","unstructured":"Jorgensen, W. L. & Duffy, E. M. Prediction of drug solubility from Monte Carlo simulations. Bioorg. Med. Chem. Lett. 10 (11), 1155\u20131158. https:\/\/doi.org\/10.1016\/S0960-894X(00)00172-4 (2000).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"26473_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0169-409X(02)00008-X","volume":"54","author":"WL Jorgensen","year":"2002","unstructured":"Jorgensen, W. L. & Duffy, E. M. Prediction of drug solubility from structure. Adv. Drug Deliv Rev. 54 (3), 355\u2013366. https:\/\/doi.org\/10.1016\/S0169-409X(02)00008-X (2002).","journal-title":"Adv. Drug Deliv Rev."},{"key":"26473_CR41","doi-asserted-by":"publisher","unstructured":"Peterson, L. COVID-19 and flavonoids: In silico molecular dynamics docking to the active catalytic site of SARS-CoV and SARS-CoV-2 main protease. Available at SSRN https:\/\/ssrn.com\/abstract=3599426 or https:\/\/doi.org\/10.2139\/ssrn.3599426 (2020).","DOI":"10.2139\/ssrn.3599426"},{"key":"26473_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.lfs.2016.10.009","volume":"166","author":"P Sneha","year":"2016","unstructured":"Sneha, P. & Doss, C. G. P. Gliptins in managing diabetes-Reviewing computational strategy. Life Sci. 166, 108\u2013120. https:\/\/doi.org\/10.1016\/j.lfs.2016.10.009 (2016).","journal-title":"Life Sci."},{"issue":"12","key":"26473_CR43","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1080\/07391102.2020.1776157","volume":"39","author":"S Gupta","year":"2021","unstructured":"Gupta, S. et al. Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular Docking and simulation studies. J. Biomol. Struct. Dyn. 39 (12), 4334\u20134345. https:\/\/doi.org\/10.1080\/07391102.2020.1776157 (2021).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"26473_CR44","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s11030-023-10648-0","volume":"28","author":"S Ahmad","year":"2024","unstructured":"Ahmad, S. & Raza, K. Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study. Mol. Diversity. 28 (3), 1189\u20131202 (2024).","journal-title":"Mol. Diversity"},{"issue":"5","key":"26473_CR45","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1080\/07391102.2023.2209673","volume":"42","author":"S Ahmad","year":"2024","unstructured":"Ahmad, S., Singh, V., Gautam, H. K. & Raza, K. Multisampling-based Docking reveals Imidazolidinyl Urea as a multitargeted inhibitor for lung cancer: an optimisation followed multi-simulation and in-vitro study. J. Biomol. Struct. Dynamics. 42 (5), 2494\u20132511 (2024).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"26473_CR46","doi-asserted-by":"publisher","first-page":"118901","DOI":"10.1016\/j.molliq.2022.118901","volume":"354","author":"S Ghahremanian","year":"2022","unstructured":"Ghahremanian, S., Rashidi, M. M., Raeisi, K. & Toghraie, D. Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review. J. Mol. Liq. 354, 118901 (2022).","journal-title":"J. Mol. Liq."},{"issue":"1","key":"26473_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5713\/ab.24.0291","volume":"38","author":"KK Ranaweera","year":"2024","unstructured":"Ranaweera, K. K. & Baik, M. In Silico Docking and molecular dynamics for the discovery of inhibitors of enteric methane production in ruminants\u2014A review. Anim. Bioscience. 38 (1), 1 (2024).","journal-title":"Anim. Bioscience"},{"issue":"11","key":"26473_CR48","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.3390\/ijms21113922","volume":"21","author":"M Hagar","year":"2020","unstructured":"Hagar, M., Ahmed, H. A., Aljohani, G. & Alhaddad, O. A. Investigation of some antiviral N-heterocycles as COVID 19 drug: molecular Docking and DFT calculations. Int. J. Mol. Sci. 21 (11), 3922 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"26473_CR49","doi-asserted-by":"publisher","first-page":"128715","DOI":"10.1016\/j.molstruc.2020.128715","volume":"1220","author":"MA Mumit","year":"2020","unstructured":"Mumit, M. A. et al. DFT studies on vibrational and electronic spectra, HOMO\u2013LUMO, MEP, HOMA, NBO and molecular Docking analysis of benzyl-3-N-(2, 4, 5-trimethoxyphenylmethylene) hydrazinecarbodithioate. J. Mol. Struct. 1220, 128715 (2020).","journal-title":"J. Mol. Struct."},{"issue":"5","key":"26473_CR50","doi-asserted-by":"publisher","first-page":"100433","DOI":"10.1016\/j.jics.2022.100433","volume":"99","author":"MB Singh","year":"2022","unstructured":"Singh, M. B. et al. An in Silico investigation for acyclovir and its derivatives to fight the COVID-19: molecular docking, DFT calculations, ADME and td-Molecular dynamics simulations. J. Indian Chem. Soc. 99 (5), 100433 (2022).","journal-title":"J. Indian Chem. Soc."},{"issue":"1","key":"26473_CR51","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1080\/07391102.2023.2201835","volume":"42","author":"V Zarezade","year":"2024","unstructured":"Zarezade, V. et al. Paradoxical effect of A\u03b2 on protein levels of ABCA1 in astrocytes, microglia, and neurons isolated from C57BL\/6 mice: an in vitro and in Silico study to elucidate the effect of A\u03b2 on ABCA1 in the brain cells. J. Biomol. Struct. Dyn. 42 (1), 274\u2013287 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"26473_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-018-3858-6","volume":"24","author":"V Zarezade","year":"2018","unstructured":"Zarezade, V., Abolghasemi, M., Rahim, F., Veisi, A. & Behbahani, M. In Silico assessment of new progesterone receptor inhibitors using molecular dynamics: a new insight into breast cancer treatment. J. Mol. Model. 24, 1\u20139 (2018).","journal-title":"J. Mol. Model."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26473-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26473-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26473-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:10:56Z","timestamp":1764249056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26473-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26473"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26473-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42412"}}